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To the Editor,
Q  fever caused by Coxiella burnetti may produce acute or
chronic clinical manifestation, although most cases are
asymptomatic or mild.1 Acute presentation of Q fever is
characterised by a sudden ﬂu-like syndrome and high-grade
fever. Nearly 1–5% of infected patients develop a chronic
form, which can take place months or years after an acute
infection. The most common manifestation is endocarditis,
especially in immunocompromised patients or in patients
with valvular heart disease. Mixed cryoglobulinaemia is rare2,3
and can be diagnosed using an immunoassay. Seroconversion
is usually detected 7–15 days after the onset of symp-
toms. Titres of anti-phase II antigens IgG greater than 200
or Titres of anti-phase II antigens IgM greater than 50
are indicative of a recent infection, whereas titres of anti-
phase I antigens IgG greater than 800 are suggestive of
 Please cite this article as: Allende Burgos N, Calls Ginesta J. Anemia
en  contexto de ﬁebre Q. Nefrología. 2015;35:586–587.yoglobulinaemia  in a
context  of Q  fever
 mixta  en  paciente  en
chronic infection. Mild forms are commonly self-limiting.
Doxycycline is the drug of choice if treatment is needed.
Hydroxychloroquine and doxycycline are recommended for
at least 18 months for the treatment of chronic forms of
endocarditis.
Our patient is a 64-year-old man  from Germany who  has
been living in Mallorca since 2011.
History:  HTN, ischaemic cardiomyopathy that underwent resistente y crioglobulinemia mixta en paciente en hemodiálisis
anticoagulation. Moderate alcoholism. End-stage chronic
renal disease (ESCRD) receiving haemodialysis with vascular
graft access.
In April 2013, the patient started with fever, elevated
transaminases (GPT 124, GOT 114, and GGT 100), and posi-
tive CMV IgM. Following 2 weeks of treatment with ganciclovir,
the fever abated but the inﬂammatory parameters remained
high (CRP 9.24 and PCT 12.48). Fever recurred subsequently
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Fig. 1 – Erythropoietin resistance rate.
and neutropenia (up to 1150 mcl), anaemia refractory to
erythropoiesis-stimulating agents (ESA) (Fig. 1), and thrombo-
cytopenia were associated. Ganciclovir was administered for
3 weeks with Rickettsia- and Coxiella-positive serologies (IgG
using IIF).
Although the patient denied any animal or tick bites, treat-
ment with doxycycline (100 mg/12 h) was initiated due to
a suspected Coxiella/Rickettsia infection and after ruling out
endocarditis using a transthoracic echocardiogram.
The patient still had fever and neutropenia seven days after
treatment began. A CT scan of the abdomen and chest revealed
liver cirrhosis and splenomegaly. HCV and HBV serologies
were negative. Finally, Serratia marcescens was isolated in a spu-
tum culture, and fever subsided following 5 days of treatment
with ceftazidime. The patient remained without fever after 2
weeks of treatment with ceftazidime and doxycycline.
Fever recurred one month later (June 2013). The sputum
culture and haemocultures were negative, while Rickettsia
and Coxiella serologies remained positive (phase 1 IgM and
IgG and phase 2 IgM and IgG [1/512; 1/2056, respectively]).
Hypergammaglobulinaemia was observed with an IgG kappa
monoclonal component, and serologies were read as false
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without a focus, which is typical of acute forms, recurrence
of symptoms following withdrawal of doxycycline was rather
suggestive of chronic Q fever.
Endocarditis is the most common presentation, particu-
larly among immunocompromised patients or patients with
valvular heart disease. And yet, surprisingly, endocarditis
was ruled out in our patient, who was immunocompromised
as a result of his baseline comorbidity (ESCRD undergoing
haemodialysis) and neutropenia.
Hepatitis and cirrhosis are also common. In our patient,
who had a history of moderate alcoholism, transaminasaemia
had remained normal before he developed his condition. Liver
cirrhosis and splenomegaly were observed in the CT scan, and
Q fever may have been a contributing factor.
Anaemia and thrombocytopenia may also occur. Our
patient already had nephropathy-related anaemia which
was initially refractory to EEAs, probably as a result of
Q fever.
Finally, the diagnosis of Q fever was reinforced by the
ﬁnding of type II cryoglobulinaemia (mono-polyclonal) in the
absence of the hepatitis C virus or haematologic neoplasia, as
it is one of its potential manifestations.4,5
Our patient started treatment with doxycycline and
hydroxychloroquine and so far, after 18 months of treatment,
the fever has not recurred and the anaemia has resolved, even
without EEAs.
In conclusion, the patient described here is a case of
chronic Q fever with blood, liver, and skin involvement,
together with secondary cryoglobulinaemia.
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